Genmab A (GMAB) Assets Average (2023 - 2026)

Genmab A's Assets Average history runs 4 years deep, the most recent figure standing at $12.6 billion for Q1 2026.

• Quarterly Assets Average rose 94.22% year-over-year to $12.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.6 billion (up 94.22% YoY) and the FY2025 annual result came in at $9.7 billion, changed N/A from the prior year.
• Assets Average was $12.6 billion for Q1 2026 at Genmab A, up from $9.9 billion in the prior quarter.
• Across five years, Assets Average topped out at $10761002.6 billion in Q4 2023 and bottomed at $15035.0 in Q3 2024.
• A 4-year average of $1345131.0 billion and a median of $6.6 billion in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average sank 100.0% — and 2025, when it soared 44845260.82%.
• Genmab A's Assets Average stood at $10761002.6 billion in 2023, then sank by 100.0% to $3.2 billion in 2024, then jumped by 210.16% to $9.9 billion in 2025, then increased by 26.92% to $12.6 billion in 2026.
• Business Quant data shows GMAB's Assets Average at $12.6 billion in Q1 2026, $9.9 billion in Q4 2025, and $6.7 billion in Q3 2025.